Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product Type
1.3.2 Market Segmentation by Technology
1.3.3 Market Segmentation by Disease Type
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Geography
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.2 Breakdown of Primary Research by Industry Participant
2.2.3 Breakdown of Primary Research by Company Type
2.2.4 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 KOLs' Sources
2.6 Data Triangulation
2.7 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product Type
4.1.1.1 Reagents and kits
4.1.1.1.1 NAT
4.1.1.1.2 ELISA
4.1.1.2 Instruments
4.1.1.2.1 By platform
4.1.1.2.1.1 Automated
4.1.1.2.1.2 Semi-Automated
4.1.1.2.2 By purchase type
4.1.1.2.2.1 Outright purchase
4.1.1.2.2.2 Rental purchase
4.1.1.3 Software and services
4.1.2 By Technology
4.1.2.1 NAT
4.1.2.1.1 TMA
4.1.2.1.2 Real-time PCR
4.1.2.2 ELISA
4.1.2.2.1 CLIA
4.1.2.2.2 FIA
4.1.2.2.3 CIA
4.1.2.3 Rapid testing
4.1.2.4 Western blotting
4.1.2.5 NGS
4.1.3 By Disease Type
4.1.3.1 Cancer
4.1.3.2 Diabetes mellitus
4.1.3.3 Hypercholesterolemia
4.1.3.4 Infectious diseases
4.1.3.5 Respiratory diseases
4.1.3.6 HIV/AIDS
4.1.4 By End User
4.1.4.1 Diagnostic centers and pathology labs
4.1.4.2 Blood banks
4.1.4.3 Hospitals
4.1.4.4 Clinics
4.1.4.5 ASCs
4.1.4.6 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Approval and launch of new products
4.2.1.2 Increasing number of collaborations and agreements
4.2.2 Drivers
4.2.2.1 Regulations to ensure safety regarding blood contamination
4.2.2.2 Surging burden chronic diseases
4.2.2.3 Increasing number of blood donors
4.2.2.4 Technological advancements in screening technology
4.2.2.5 Increasing healthcare expenditure
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Challenges in maintaining sufficient safe blood supply
4.2.3.2 Data insecurity of donors' demographic information
4.2.3.3 Cost-ineffectiveness of instruments
4.2.3.4 Impact analysis of restraints on market forecast

Chapter 5. Global Market Size and Forecast
5.1 By Product Type
5.1.1 Reagents and Kits Market, by Type
5.1.1.1 NAT reagents and kits market, by type
5.1.1.2 ELISA reagents and kits market, by type
5.1.2 Instruments Market, by Platform
5.1.3 Instruments Market, by Purchase Type
5.2 By Technology
5.2.1 NAT Technology Market, by Product Type
5.2.2 NAT Technology Market, by Type
5.2.3 ELISA Technology Market, by Product Type
5.2.4 ELISA Technology Market, by Type
5.2.5 Rapid Testing Technology Market, by Product Type
5.2.6 Western Blotting Technology Market, by Product Type
5.2.7 NGS Technology Market, by Product Type
5.3 By Disease Type
5.4 By End User
5.5 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product Type
6.1.1 Reagents and Kits Market, by Type
6.1.1.1 NAT reagents and kits market, by type
6.1.1.2 ELISA reagents and kits market, by type
6.1.2 Instruments Market, by Platform
6.1.3 Instruments Market, by Purchase Type
6.2 By Technology
6.2.1 NAT Technology Market, by Product Type
6.2.2 NAT Technology Market, by Type
6.2.3 ELISA Technology Market, by Product Type
6.2.4 ELISA TECHNOLOGY MARKET, BY TYPE
6.2.5 Rapid Testing Technology Market, by Product Type
6.2.6 Western Blotting Technology Market, by Product Type
6.2.7 NGS Technology Market, by Product Type
6.3 By Disease Type
6.4 By End User
6.5 By Country

Chapter 7. Europe Market Size and Forecast
7.1 By Product Type
7.1.1 Reagents and Kits Market, by Type
7.1.1.1 NAT reagents and kits market, by type
7.1.1.2 ELISA reagents and kits market, by type
7.1.2 Instruments Market, by Platform
7.1.3 Instruments Market, by Purchase Type
7.2 By Technology
7.2.1 NAT Technology Market, by Product Type
7.2.2 NAT Technology Market, by Type
7.2.3 ELISA Technology Market, by Product Type
7.2.4 ELISA Technology Market, by Type
7.2.5 Rapid Testing Technology Market, by Product Type
7.2.6 Western Blotting Technology Market, by Product Type
7.2.7 NGS Technology Market, by Product Type
7.3 By Disease Type
7.4 By End User
7.5 By Country

Chapter 8. APAC Market Size and Forecast
8.1 By Product Type
8.1.1 Reagents and Kits Market, by Type
8.1.1.1 NAT reagents and kits market, by type
8.1.1.2 ELISA reagents and kits market, by type
8.1.2 Instruments Market, by Platform
8.1.3 Instruments Market, by Purchase Type
8.2 By Technology
8.2.1 NAT Technology Market, by Product Type
8.2.2 NAT Technology Market, by Type
8.2.3 ELISA Technology Market, by Product Type
8.2.4 ELISA Technology Market, by Type
8.2.5 Rapid Testing Technology Market, by Product Type
8.2.6 Western Blotting Technology Market, by Product Type
8.2.7 NGS Technology Market, by Product Type
8.3 By Disease Type
8.4 By End User
8.5 By Country

Chapter 9. LATAM Market Size and Forecast
9.1 By Product Type
9.1.1 Reagents and Kits Market, by Type
9.1.1.1 NAT reagents and kits market, by type
9.1.1.2 ELISA reagents and kits market, by type
9.1.2 Instruments Market, by Platform
9.1.3 Instruments Market, by Purchase Type
9.2 By Technology
9.2.1 NAT Technology Market, by Product Type
9.2.2 NAT Technology Market, by Type
9.2.3 ELISA Technology Market, by Product Type
9.2.4 ELISA Technology Market, by Type
9.2.5 Rapid Testing Technology Market, by Product Type
9.2.6 Western Blotting Technology Market, by Product Type
9.2.7 NGS Technology Market, by Product Type
9.3 By Disease Type
9.4 By End User
9.5 By Country

Chapter 10. MEA Market Size and Forecast
10.1 By Product Type
10.1.1 Reagents and Kits Market, by Type
10.1.1.1 NAT reagents and kits market, by type
10.1.1.2 ELISA reagents and kits market, by type
10.1.2 Instruments Market, by Platform
10.1.3 Instruments Market, by Purchase Type
10.2 By Technology
10.2.1 NAT Technology Market, by Product Type
10.2.2 NAT Technology Market, by Type
10.2.3 ELISA Technology Market, by Product Type
10.2.4 ELISA Technology Market, by Type
10.2.5 Rapid Testing Technology Market, by Product Type
10.2.6 Western Blotting Technology Market, by Product Type
10.2.7 NGS Technology Market, by Product Type
10.3 By Disease Type
10.4 By End User
10.5 By Country

Chapter 11. Major Markets: Segment Analysis
11.1 U.S.
11.1.1 U.S. Blood Screening Market, by Product Type
11.1.2 U.S. Blood Screening Market, by Technology
11.2 Canada
11.2.1 Canada Blood Screening Market, by Product Type
11.2.2 Canada Blood Screening Market, by Technology
11.3 Germany
11.3.1 Germany Blood Screening Market, by Product Type
11.3.2 Germany Blood Screening Market, by Technology
11.4 France
11.4.1 France Blood Screening Market, by Product Type
11.4.2 France Blood Screening Market, by Technology
11.5 U.K.
11.5.1 U.K. Blood Screening Market, by Product Type
11.5.2 U.K. Blood Screening Market, by Technology
11.6 Italy
11.6.1 Italy Blood Screening Market, by Product Type
11.6.2 Italy Blood Screening Market, by Technology
11.7 Spain
11.7.1 Spain Blood Screening Market, by Product Type
11.7.2 Spain Blood Screening Market, by Technology
11.8 China
11.8.1 China Blood Screening Market, by Product Type
11.8.2 China Blood Screening Market, by Technology
11.9 Japan
11.9.1 Japan Blood Screening Market, by Product Type
11.9.2 Japan Blood Screening Market, by Technology
11.10 India
11.10.1 India Blood Screening Market, by Product Type
11.10.2 India Blood Screening Market, by Technology

Chapter 12. Competitive Landscape
12.1 Market Share Analysis of Key Players
12.2 Products Benchmarking of Key Players
12.3 Strategic Developments in the Market
12.3.1 Product Approvals/Launches
12.3.2 Collaborations/Acquisitions/Agreements
12.3.3 Other Developments

Chapter 13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Business Overview
13.1.2 Product and Service Offerings
13.1.3 Key Financial Summary
13.2 Bio-Rad Laboratories Inc.
13.2.1 Business Overview
13.2.2 Product and Service Offerings
13.2.3 Key Financial Summary
13.3 Becton, Dickinson and Company
13.3.1 Business Overview
13.3.2 Product and Service Offerings
13.3.3 Key Financial Summary
13.4 General Electric Company
13.4.1 Business Overview
13.4.2 Product and Service Offerings
13.4.3 Key Financial Summary
13.5 Thermo Fisher Scientific Inc.
13.5.1 Business Overview
13.5.2 Product and Service Offerings
13.5.3 Key Financial Summary
13.6 Merck KGaA
13.6.1 Business Overview
13.6.2 Product and Service Offerings
13.6.3 Key Financial Summary
13.7 Siemens AG
13.7.1 Business Overview
13.7.2 Product and Service Offerings
13.7.3 Key Financial Summary
13.8 Grifols S.A.
13.8.1 Business Overview
13.8.2 Product and Service Offerings
13.8.3 Key Financial Summary
13.9 Ortho-Clinical Diagnostics Inc.
13.9.1 Business Overview
13.9.2 Product and Service Offerings
13.10 DiaSorin S.p.A.
13.10.1 Business Overview
13.10.2 Product and Service Offerings
13.10.3 Key Financial Summary
13.11 J. Mitra & Co. Pvt. Ltd.
13.11.1 Business Overview
13.11.2 Product and Service Offerings
13.12 Bio-Techne Corporation
13.12.1 Business Overview
13.12.2 Product and Service Offerings
13.12.3 Key Financial Summary
13.13 Trinity Biotech plc
13.13.1 Business Overview
13.13.2 Product and Service Offerings
13.13.3 Key Financial Summary
13.14 Gesellschaft zur Forschung, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE)
13.14.1 Business Overview
13.14.2 Product and Service Offerings
13.15 Danaher Corporation
13.15.1 Business Overview
13.15.2 Product and Service Offerings
13.15.3 Key Financial Summary
13.16 F. Hoffmann-La Roche Ltd.
13.16.1 Business Overview
13.16.2 Product and Service Offerings
13.16.3 Key Financial Summary
13.17 PerkinElmer Inc.
13.17.1 Business Overview
13.17.2 Product and Service Offerings
13.17.3 Key Financial Summary
13.18 bioMérieux S.A.
13.18.1 Business Overview
13.18.2 Product and Service Offerings
13.18.3 Key Financial Summary

Chapter 14. Appendix
14.1 Abbreviations
14.2 Sources and References
14.3 Related Reports

LIST OF TABLES
TABLE 1 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 1 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 2 GLOBAL BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 3 GLOBAL BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 4 GLOBAL BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 5 GLOBAL BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 6 GLOBAL NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 7 GLOBAL NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 8 GLOBAL ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 9 GLOBAL ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 10 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 11 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 12 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 13 GLOBAL BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 14 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 15 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 16 GLOBAL NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 17 GLOBAL NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 18 GLOBAL NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 19 GLOBAL NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 20 GLOBAL ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 21 GLOBAL ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 22 GLOBAL ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 23 GLOBAL ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 24 GLOBAL RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 25 GLOBAL RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 26 GLOBAL WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 27 GLOBAL WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 28 GLOBAL NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 29 GLOBAL NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 30 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 31 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 32 GLOBAL BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 33 GLOBAL BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 34 GLOBAL BLOOD SCREENING MARKET, BY REGION, $M (2014-2019)
TABLE 35 GLOBAL BLOOD SCREENING MARKET, BY REGION, $M (2020-2030)
TABLE 36 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 37 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 38 NORTH AMERICA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 39 NORTH AMERICA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 40 NORTH AMERICA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 41 NORTH AMERICA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 42 NORTH AMERICA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 43 NORTH AMERICA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 44 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 45 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 46 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 47 NORTH AMERICA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 48 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 49 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 50 NORTH AMERICA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 51 NORTH AMERICA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 52 NORTH AMERICA NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 53 NORTH AMERICA NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 54 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 55 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 56 NORTH AMERICA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 57 NORTH AMERICA TECHNOLOGY MARKET, BY ELISA, $M (2020-2030)
TABLE 58 NORTH AMERICA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 59 NORTH AMERICA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 60 NORTH AMERICA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 61 NORTH AMERICA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 62 NORTH AMERICA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 63 NORTH AMERICA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 64 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 65 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 66 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 67 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 68 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 69 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 70 EUROPE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 71 EUROPE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 72 EUROPE BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 73 EUROPE BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 74 EUROPE NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 75 EUROPE NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 76 EUROPE ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 77 EUROPE ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 78 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 79 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 80 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 81 EUROPE BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 82 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 83 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 84 EUROPE NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 85 EUROPE NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 86 EUROPE NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 87 EUROPE NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 88 EUROPE ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 89 EUROPE ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 90 EUROPE ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 91 EUROPE ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 92 EUROPE RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 93 EUROPE RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 94 EUROPE WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 95 EUROPE WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 96 EUROPE NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 97 EUROPE NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 98 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 99 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 100 EUROPE BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 101 EUROPE BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 102 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 103 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 104 APAC BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 105 APAC BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 106 APAC BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 107 APAC BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 108 APAC NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 109 APAC NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 110 APAC ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 111 APAC ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 112 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 113 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 114 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 115 APAC BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 116 APAC BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 117 APAC BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 118 APAC NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 119 APAC NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 120 APAC NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 121 APAC NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 122 APAC ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 123 APAC ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 124 APAC ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 125 APAC ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 126 APAC RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 127 APAC RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 128 APAC WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 129 APAC WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 130 APAC NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 131 APAC NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 132 APAC BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 133 APAC BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 134 APAC BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 135 APAC BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 136 APAC BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 137 APAC BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 138 LATAM BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 139 LATAM BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 140 LATAM BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 141 LATAM BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 142 LATAM NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 143 LATAM NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 144 LATAM ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 145 LATAM ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 146 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 147 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 148 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 149 LATAM BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 150 LATAM BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 151 LATAM BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 152 LATAM NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 153 LATAM NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 154 LATAM NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 155 LATAM NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 156 LATAM ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 157 LATAM ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 158 LATAM ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 159 LATAM ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 160 LATAM RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 161 LATAM RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 162 LATAM WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 163 LATAM WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 164 LATAM NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 165 LATAM NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 166 LATAM BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 167 LATAM BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 168 LATAM BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 169 LATAM BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 170 LATAM BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 171 LATAM BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 172 MEA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 173 MEA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 174 MEA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 175 MEA BLOOD SCREENING REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 176 MEA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 177 MEA NAT REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 178 MEA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2014-2019)
TABLE 179 MEA ELISA REAGENTS AND KITS MARKET, BY TYPE, $M (2020-2030)
TABLE 180 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2014-2019)
TABLE 181 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PLATFORM, $M (2020-2030)
TABLE 182 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2014-2019)
TABLE 183 MEA BLOOD SCREENING INSTRUMENTS MARKET, BY PURCHASE TYPE, $M (2020-2030)
TABLE 184 MEA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 185 MEA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 186 MEA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 187 MEA NAT TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 188 MEA NAT TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 189 MEA NAT TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 190 MEA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 191 MEA ELISA TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 192 MEA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2014-2019)
TABLE 193 MEA ELISA TECHNOLOGY MARKET, BY TYPE, $M (2020-2030)
TABLE 194 MEA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 195 MEA RAPID TESTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 196 MEA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 197 MEA WESTERN BLOTTING TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 198 MEA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 199 MEA NGS TECHNOLOGY MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 200 MEA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2014-2019)
TABLE 201 MEA BLOOD SCREENING MARKET, BY DISEASE TYPE, $M (2020-2030)
TABLE 202 MEA BLOOD SCREENING MARKET, BY END USER, $M (2014-2019)
TABLE 203 MEA BLOOD SCREENING MARKET, BY END USER, $M (2020-2030)
TABLE 204 MEA BLOOD SCREENING MARKET, BY COUNTRY, $M (2014-2019)
TABLE 205 MEA BLOOD SCREENING MARKET, BY COUNTRY, $M (2020-2030)
TABLE 206 U.S. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 207 U.S. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 208 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 209 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 210 CANADA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 211 CANADA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 212 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 213 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 214 GERMANY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 215 GERMANY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 216 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 217 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 218 FRANCE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 219 FRANCE BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 220 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 221 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 222 U.K. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 223 U.K. BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 224 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 225 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 226 ITALY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 227 ITALY BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 228 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 229 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 230 SPAIN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 231 SPAIN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 232 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 233 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 234 CHINA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 235 CHINA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 236 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 237 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 238 JAPAN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 239 JAPAN BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 240 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 241 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 242 INDIA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2014-2019)
TABLE 243 INDIA BLOOD SCREENING MARKET, BY PRODUCT TYPE, $M (2020-2030)
TABLE 244 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 245 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 246 PRODUCT BENCHMARKING OF KEY PLAYERS
TABLE 247 ABBOTT LABORATORIES - AT A GLANCE
TABLE 248 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
TABLE 249 BIO-RAD LABORATORIES INC. - AT A GLANCE
TABLE 250 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
TABLE 251 BECTON, DICKINSON AND COMPANY - AT A GLANCE
TABLE 252 BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
TABLE 253 GENERAL ELECTRIC COMPANY - AT A GLANCE
TABLE 254 GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY
TABLE 255 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
TABLE 256 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
TABLE 257 MERCK KGAA - AT A GLANCE
TABLE 258 MERCK KGAA - KEY FINANCIAL SUMMARY
TABLE 259 SIEMENS AG - AT A GLANCE
TABLE 260 SIEMENS AG - KEY FINANCIAL SUMMARY
TABLE 261 GRIFOLS S.A. - AT A GLANCE
TABLE 262 GRIFOLS S.A. - KEY FINANCIAL SUMMARY
TABLE 263 ORTHO-CLINICAL DIAGNOSTICS INC. - AT A GLANCE
TABLE 264 ORTHO-CLINICAL DIAGNOSTICS INC. - PRODUCT AND SERVICE OFFERINGS
TABLE 265 DIASORIN S.P.A. - AT A GLANCE
TABLE 266 DIASORIN S.P.A. - PRODUCT AND SERVICE OFFERINGS
TABLE 267 DIASORIN S.P.A. - KEY FINANCIAL SUMMARY
TABLE 268 J. MITRA & CO. PVT. LTD. - AT A GLANCE
TABLE 269 J. MITRA & CO. PVT. LTD. - PRODUCT AND SERVICE OFFERINGS
TABLE 270 BIO-TECHNE CORPORATION - AT A GLANCE
TABLE 271 BIO-TECHNE CORPORATION - KEY FINANCIAL SUMMARY
TABLE 272 TRINITY BIOTECH PLC - AT A GLANCE
TABLE 273 TRINITY BIOTECH PLC. - KEY FINANCIAL SUMMARY
TABLE 274 GFE - AT A GLANCE
TABLE 275 DANAHER CORPORATION - AT A GLANCE
TABLE 276 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
TABLE 277 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
TABLE 278 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
TABLE 279 PERKINELMER INC. - AT A GLANCE
TABLE 280 PERKINELMER INC. - KEY FINANCIAL SUMMARY
TABLE 281 BIOMÉRIEUX S.A. - AT A GLANCE
TABLE 282 BIOMÉRIEUX S.A. - KEY FINANCIAL SUMMARY

Companies Mentioned
Abbott Laboratories
Bio-Rad Laboratories Inc.
Becton, Dickinson and Company
General Electric Company
Thermo Fisher Scientific Inc.
Merck KGaA
Siemens AG
Grifols S.A.
Ortho-Clinical Diagnostics Inc.
DiaSorin S.p.A.
J. Mitra & Co. Pvt. Ltd.
Bio-Techne Corporation
Trinity Biotech plc
Gesellschaft zur Forschung, Entwicklung und Distribution von Diagnostika im Blutspendewesen mbH (GFE)
Danaher Corporation
F. Hoffmann-La Roche Ltd.
PerkinElmer Inc.
bioMérieux S.A.